Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of Oncology

Volume 31, Issue 11, November 2020, Pages 1462-1475

Under an Elsevier user license

open archive

•
This EHNS–ESMO–ESTRO Clinical Practice Guideline provides key recommendations for managing SCCHN.
•
It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.
•
Opportunities for personalised medicine in SCCHN are also discussed.
•
All recommendations were compiled by a multidisciplinary group of experts from different institutions and countries.
•
Recommendations are based on available clinical evidence and the collective expert opinion of the authors.

SCCHN

Clinical Practice Guidelines

diagnosis

treatment

follow-up

^†: These Guidelines were developed by the European Head and Neck Society (EHNS), the European Society for Medical Oncology (ESMO) and the European SocieTy for Radiotherapy & Oncology (ESTRO). The three societies nominated authors to write the guidelines as well as reviewers to comment on them. These guidelines were approved by the EHNS Executive Board, the ESMO Guidelines Committee and the ESTRO Executive Board in June 2020.